Peripheral nerve complications of weight loss associated with novel antihyperglycemic agents: a cohort study
{{output}}
Introduction: Weight loss can cause or exacerbate peripheral nerve disorders, including peripheral neuropathy and entrapments. Novel antihyperglycaemic agents, including glucagon-like peptide-1 receptor (GLP1R) agonists and sodiu... ...
